Recent Finacing
Recent Raise
Global Blood Therapeutics develops orally available small-molecule allosteric modulators using its SHAPE platform to alter hemoglobin conformation, advancing GBT440 for sickle cell disease and hypoxic disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
